Concepedia

Melinda A. Biernacki

MA

Statistics

Publications

15

Citations

684

H-Index

13

Active since

2003

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

University of Washington

Fred Hutch Cancer Center

Brigham and Women's Hospital

Melinda A. Biernacki is an author at Dana-Farber Cancer Institute specializing in medicine, cell transplantation, and cellular therapies.

ORCID

Top concepts

Publications per year

2003–2024

15

Publications

15

Stable Long-Term Donor Engraftment following Reduced-Intensity Hematopoietic Cell Transplantation for Sickle Cell Disease

Lakshmanan Krishnamurti, Sandhya Kharbanda, Melinda A. Biernacki et al. · Biology of Blood and Marrow Transplantation · 2008 · 127 citations · Full text

Evidence for ineffective erythropoiesis in severe sickle cell disease

Catherine J. Wu, Lakshmanan Krishnamurti, Jeffery L. Kutok et al. · Blood · 2005 · 95 citations · Full text

Development of T-cell immunotherapy for hematopoietic stem cell transplantation recipients at risk of leukemia relapse

Robson G. Dossa, Tanya Cunningham, Daniel Sommermeyer et al. · Blood · 2017 · 89 citations · Full text

A Ratiometric Expressible FRET Sensor for Phosphoinositides Displays a Signal Change in Highly Dynamic Membrane Structures in Fibroblasts

Gregor Cicchetti, Melinda A. Biernacki, Jessica Farquharson et al. · Biochemistry · 2004 · 62 citations

, , +17

Graft-versus-Leukemia Target Antigens in Chronic Myelogenous Leukemia Are Expressed on Myeloid Progenitor Cells

Catherine J. Wu, Melinda A. Biernacki, Jeffery L. Kutok et al. · Clinical Cancer Research · 2005 · 55 citations · Full text

Rows per page

1–5 of 15